Non-small cell lung cancerQuestions to ask your doctor
The most common form of lung cancer. Subtype, stage, and biomarker test results shape which treatments are considered.
Preview — not yet published
This page is in editorial and medical review. Content below is a scaffold — treat it as a preview, not guidance.
Practical prompts to bring to your next appointment — not a script, a starting point.
Which subtype do I have (adenocarcinoma, squamous, or other)?
What stage is it, and has it spread outside the lung?
Has my tumor been tested for biomarkers like EGFR, ALK, or PD-L1?
Biomarker results open up targeted therapies and immunotherapies for some patients.
Am I a candidate for surgery, radiation, targeted therapy, or immunotherapy?
Are there clinical trials for my subtype or biomarker profile?
A note on using this list
Bring the 3–5 questions that matter most to you, not all of them. It’s also fine to take notes during the appointment, or bring someone with you who can.
Review, sources, and disclaimer
How this page was reviewed
Pending medical review. This page will list the reviewing clinician and review date before publication.
Sources will be listed here before publication. We prefer guideline-level and patient-trusted references.
This page is educational, not medical advice. Talk with your care team about decisions that apply to you. If something feels urgent, contact your doctor — or, for emergencies, call your local emergency number.